ZBIO
Zenas BioPharma, Inc.
+0.25 (+0.77%)32.57USD180K成交股數2.1B市值–本益比(近四季)2122.8股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.0M | – | – | 0.00 | 0.00 | 0.00 | 10.0M | 0.00-100% | 0.00 | – | – | 50.0M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 62.9M | 60.4M | – | 55.7M | 34.4M | 43.0M | 34.9M | 33.5M | 33.8M | 22.6M | – | 9.4M |
| 銷售管理費用 | 15.7M | 16.9M | – | 15.6M | 13.2M | 12.1M | 12.4M | 7.5M | 5.9M | 4.9M | – | 5.0M |
| 營業利益 | −108M+105% | −77.4M+40% | – | −238M+481% | −52.6M+32% | −55.2M+100% | −37.3M | −41.0M-215% | −39.7M | −27.6M | – | 35.6M |
| 營業利益率 | -10,765.9% | – | – | – | – | – | -373.3% | – | – | – | – | 71.2% |
| 稅後淨利 | −111M+116% | −81.0M+55% | −112M+232% | −240M+523% | −51.5M+36% | −52.2M+88% | −33.6M+37% | −38.6M-208% | −38.0M | −27.8M | −24.6M | 35.6M |
| 淨利率 | -11,145.6% | – | – | – | – | – | -335.7% | – | – | – | – | 71.2% |
| 稀釋 EPS | -1.77+45% | -1.46+17% | – | -5.17+3% | -1.22-95% | -1.25-93% | -0.80 | -5.02-356% | -24.23 | -17.89 | – | 1.96 |
| 稀釋股數 | 63.1M | 55.6M | – | 44.7M | 42.2M | 41.9M | 41.8M | 7.7M | 1.6M | 1.6M | 1.5M | 1.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 197M | 500M | – | 111M | 116M | 44.0M | 197M | 360M | 184M | 37.2M | 56.9M | 72.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 702M | 748M | – | 384M | 322M | 293M | 334M | 403M | – | – | 68.2M | – |
| 有息負債 | – | – | – | 78.6M | 73.0M | – | – | – | – | – | – | – |
| 總負債 | 455M | 412M | – | 141M | 126M | 53.5M | 49.4M | 44.0M | – | – | 43.8M | – |
| 股東權益 | 247M | 336M | – | 242M | 196M | 240M | 284M | 359M | −289M | −252M | −226M | −202M |
| 負債比 | 64.8% | 55.1% | – | 36.9% | 39.0% | 18.2% | 14.8% | 10.9% | – | – | 64.3% | – |
| 淨現金(現金 − 有息負債) | – | – | – | 32.0M | 42.6M | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −75.2M | – | – | – | – | −37.1M | – | – | −19.1M | – | – |
| 資本支出 | – | 2K | – | – | – | – | 18K | – | – | 22K | – | – |
| 自由現金流 | – | −75.2M | – | – | – | – | −37.1M | – | – | −19.1M | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | -370.7% | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 10.0M
| Single Reportable | 10.0M | 100.0% | +100.0% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 10.0M | +100.0% | −378M | -3,777.4% | -8.44 | −172M |
| FY2024 | 5.0M | -90.0% | −157M | -3,139.8% | -11.89 | −120M |
| FY2023 | 50.0M | – | −37.1M | -74.2% | -24.25 | −30.5M |